Welcome to our dedicated page for ITRON SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Itron Inc. filings document the reporting, governance and capital-structure records of an operating company serving utility and city infrastructure markets. Recent 8-K disclosures cover operating results, financial-condition updates, material agreements and the issuance of convertible senior notes, including purchase agreement and indenture terms tied to the company’s debt and equity structure.
Proxy and shareholder-vote filings describe director elections, advisory executive-compensation votes and annual meeting matters for holders of Itron common stock. Other material-event filings record cybersecurity response and operational-continuity disclosures, while exchange-registration information identifies ITRI common stock, no par value, as listed on the Nasdaq Global Select Market.
Vanguard Portfolio Management reports beneficial ownership of 3,534,821 shares of Itron Inc. Common Stock. The filing states this equals 7.97% of the class and shows sole dispositive power over 3,534,821 shares with sole voting power for 28,154 shares. The filing notes these holdings include securities held for Vanguard funds and other managed accounts.
Itron, Inc. reported quarterly revenue of $586.982 million, down from $607.151 million a year earlier, as lower product sales were partly offset by higher service revenue. Net income attributable to Itron was $53.459 million versus $65.474 million, with diluted EPS of $1.18 compared with $1.42.
Operating cash flow increased to $85.501 million, but cash and cash equivalents fell to $712.850 million from $1.020 billion, mainly due to acquisitions and financing actions. Itron completed the $546.6 million cash acquisition of Locusview and now reports a new Resiliency Solutions segment.
The company issued $805 million of new 2026 convertible notes, repaid $460 million of 2021 notes, and ended the quarter with total debt of $1.61 billion. It also repurchased about 1.05 million shares for $100 million, while total remaining performance obligations were about $2.0 billion, split roughly between the next 12 months and later periods.
Itron, Inc. reported first quarter 2026 revenue of $587 million, down from $607 million a year earlier, mainly from portfolio optimization and project timing. GAAP net income attributable to Itron was $53 million, or $1.18 diluted EPS, compared with $65 million, or $1.42 per share.
Non-GAAP diluted EPS was $1.49 versus $1.52, while adjusted EBITDA rose to $92 million, up 5%. Adjusted gross margin improved to 40.7%, helped by favorable mix and efficiencies, even as GAAP operating expenses increased with the Urbint and Locusview acquisitions.
Free cash flow strengthened to $79 million from $67 million, and quarter-end backlog was $4.4 billion versus $4.7 billion. For Q2 2026, the company guides revenue between $560–$570 million and non-GAAP diluted EPS between $1.25–$1.35.
Itron, Inc. reported that on April 13, 2026 an unauthorized third party gained access to certain company systems. Itron activated its cybersecurity response plan, engaged external advisors, notified law enforcement, and undertook remediation efforts.
The company states it has removed the unauthorized activity, seen no further unauthorized access within its corporate systems, and observed no unauthorized activity in customer-hosted systems. Operations have continued in all material respects, supported by contingency and data backup plans. Itron currently expects a significant portion of direct incident-related costs to be reimbursed by insurance and does not currently believe the incident has had or is reasonably likely to have a material impact.
Itron, Inc. director Sheri Savage received a stock grant of 580 shares of Common Stock as part of her quarterly board compensation. The shares were awarded at no cash cost to her and are classified as a grant or other acquisition. Following this grant, she directly holds 1,766 shares of Itron common stock.
Perez Santiago reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Perez Santiago received a grant of 580 shares of common stock on April 1, 2026. This award is part of the quarterly stock compensation that independent board members receive for their service. After this grant, Perez Santiago directly owns 11,898 shares of Itron common stock.
Mirchandani Sanjay reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Sanjay Mirchandani received a stock grant of 580 shares of common stock as part of his quarterly board compensation. This grant was awarded at no cash cost per share and increased his direct holdings to 6,203 common shares following the transaction.
LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Timothy M. Leyden received a grant of 232 shares of common stock as part of the quarterly compensation that independent board members receive. The award was at no cash cost per share and increased his direct holdings to 16,005 shares.
According to the disclosure, Leyden deferred receipt of 87 of these shares under Itron's Executive Deferred Compensation Plan, so only part of the award was taken immediately in stock while the remainder was deferred.
Lande Jerome J. reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Jerome J. Lande received a grant of 580 shares of common stock on April 1, 2026 as part of the quarterly equity compensation paid to independent members of the board for their annual board service. Following this award, he directly holds 10,144 common shares.
JAEHNERT FRANK M reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Frank M. Jaehnert received a grant of 580 shares of common stock as part of his board compensation. The award was made at a stated price of $0.00 per share, reflecting a non-cash stock grant rather than an open-market purchase. Following this grant, he directly holds 22,497 shares of Itron common stock. According to the disclosure, Mr. Jaehnert deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, making this a routine, compensation-related equity award for an independent board member.